Related Experiment Videos
Duro-pleural fistula diagnosed by beta2-transferrin
John T Huggins1, Steven A Sahn
1Division of Pulmonary and Critical Care Medicine, Allergy and Clinical Immunology, Medical University of South Carolina, Charleston, SC 29425, USA.
Respiration; International Review of Thoracic Diseases
|September 27, 2003
Summary
This case report details a rare duro-pleural fistula diagnosed using beta2-transferrin in pleural fluid. This biomarker aids in identifying cerebrospinal fluid leaks, offering a novel diagnostic approach for such effusions.
Area of Science:
- Pulmonology
- Neurosurgery
- Clinical Diagnostics
Background:
- Chronic pleural effusions can present diagnostic challenges.
- Duro-pleural fistulas are rare complications, often following spinal surgery.
- Identifying cerebrospinal fluid (CSF) in pleural fluid is crucial for diagnosis.
Observation:
- An 81-year-old male presented with chronic, transudative pleural effusion requiring frequent thoracenteses.
- The patient had a history of extensive lumbar disk surgery.
- Pleural fluid analysis revealed low protein, normal LDH, glucose, and alkaline pH, mimicking other effusions.
Findings:
- Diagnosis of a duro-pleural fistula was confirmed by detecting beta2-transferrin in the pleural fluid.
- Beta2-transferrin is a specific marker for cerebrospinal fluid.
- This is the first reported instance of beta2-transferrin detection in pleural fluid secondary to a duro-pleural fistula.
Implications:
- Beta2-transferrin testing can be a valuable tool for diagnosing duro-pleural fistulas.
- This finding expands the utility of beta2-transferrin beyond cranial CSF leaks.
- Early and accurate diagnosis can guide appropriate surgical or conservative management.